Abstract
To better understand the distinct physiological roles played by progesterone and estrogen receptors (PR amd ER)4 as well as to study directly PR function in an in vivo context, a novel mutant mouse strain, the PR knockout (PRKO) mouse, was generated carrying a germline loss of function mutation at the PR locus. Mouse mammary gland development has been examined in PRKO mice using reciprocal transplantation experiments to investigate the effects of the stromal and epithelial PRs on ductal and lobuloalveolar development. The absence of PR in transplanted donor epithelium, but not in recipient stroma, prevented normal lobuloalveolar development in response to estrogen and progesterone treatment. Conversely, the presence of PR in the transplanted donor epithelium, but not in the recipient stroma, revealed that PR in the stroma may be necessary for ductal development. Stimulation of ductal development by the PR may, therefore, be mediated by an unknown secondary signaling molecule, possibly a growth factor. The continued stimulation of the stromal PR appears to be dependent on reciprocal signal(s) from the epithelium. Thus, the combination of gene knockout and reciprocal transplantation technologies has provided some new insights into the role of stromal-epithelial interactions and steroid hormones in mammary gland development.
Similar content being viewed by others
REFERENCES
Y. J. Topper and C. S. Freeman (1980). Multiple hormone interactions in the developmental biology of the mammary gland. Physiol. Rev. 60:1049–1106.
C. H. Knight and M. Peaker (1982). Development of the mammary gland. J. Reprod. Fertil. 65:521–536.
S. Nandi (1959). Hormonal control of mammogenesis and lactogenesis in the C3H/He Crgl mouse. In C. Stern, S. Benson, and W. Quay (eds.), University of California Berkeley Publications in Zoology, University of California Press, Berkeley, pp. 1–128.
B. Heuberger, I. Fitzka, G. Wasner, and K. Kratochwil (1982). Induction of androgen receptor formation by epithelium-mesenchyme interaction in embryonic mouse mammary gland. Proc. Natl. Acad. Sci. U.S.A. 79:2957–2961.
H. Durnberger, B. Heuberger, P. Schwartz, G. Wasner, and K. Kratochwil (1978). Mesenchyme-mediated effect of testosterone on embryonic mammary epithelium. Cancer Res. 38:4066–4070.
T. Sakakura, I. Kusano, M. Kusakabe, Y. Inaguma, and Y. Nishizuka (1987). Biology of mammary fat pad in fetal mouse: capacity to support development of various fetal epithelia in vivo. Development 100:421–430.
T. Sakakura, Y. Nishizuka, and C. J. Dawe (1979). Capacity of mammary fat pads of adult C3H/HeMs mice to interact morphogenetically with fetal mammary epithelium. J. Natl. Cancer Inst. 63:733–736.
T. Sakakura, Y. Nishizuka, and C. J. Dawe (1976). Mesenchyme-dependent morphogenesis and epithelium-specific cyto-differentiation in mouse mammary gland. Science 194:1439–1441.
K. B. DeOme, L. J. Faulkin, H. A. Bern, and P. B. Blair (1958). Development of mammary tumors from hyperplastic alveolar nodules transplanted into gland-free mammary pads of female C3H mice. Cancer Res. 19:515–519.
K. Kratochwil (1977). Development and loss of androgen responsiveness in the embryonic rudiment of the mouse mammary gland. Devel. Biol. 61:358–365.
K. Kratochwil and P. Schwartz (1976). Tissue interaction in androgen response of embryonic mammary rudiment of mouse: identification of target tissue for testosterone. Proc. Natl. Acad. Sci. U.S.A. 73:4041–4044.
T. Sakakura (1987). Mammary embryogenesis. In M. C. Neville and C. W. Daniel (eds.), The Mammary Gland, Plenum Press, New York, pp. 37–66.
S. Z. Haslam and L. J. Counterman (1991). Mammary stroma modulates hormonal responsiveness of mammary epithelium in vivo in the mouse. Endocrinology 129:2017–2023.
G. R. Cunha (1994). Role of mesenchymal-epithelial interactions in normal and abnormal development of the mammary gland and prostate. Cancer 74:1030–1044.
G. R. Cunha, P. Young, S. Hamamoto, R. Guzman, and S. Nandi (1992). Developmental response of adult mammary epithelial cells to various fetal and neonatal mesenchymes. Epithelial Cell Biol. 1:105–118.
S. J. Haslam (1988). Progesterone effects on deoxyribonucleic acid synthesis in normal mouse mammary glands. Endocrinology 122:464–470.
S. Z. Haslam (1988). Acquisition of estrogen-dependent progesterone receptors by normal mouse mammary gland. Ontogeny of mammary progesterone receptors. J. Steroid Biochem. 31:9–13.
S. Z. Haslam and G. Shyamala (1981). Relative distribution of estrogen and progesterone receptors among the epithelial, adipose, and connective tissue components of the normal mammary gland. Endocrinology 108:825–830.
S. Wang, L. J. Counterman, and S. Z. Haslam (1990). Progesterone action in normal mouse mammary gland. Endocrinology 127:2183–2189.
J. P. Lydon, F. J. DeMayo, C. R. Funk, S. K. Mani, A. R. Hughes, C. A. Montgomery Jr., G. Shyamala, O. M. Conneely, and B. W. O'Malley (1995). Mice lacking progesterone receptor exhibit pleiotropic reproductive abnormalities. Genes Devel. 9:2266–2278.
C. W. Daniel and G. B. Silberstein (1987). Postnatal development of the rodent mammary gland. In M. C. Neville and C. W. Daniel (eds.), The Mammary Gland, Plenum Press, New York, pp. 3–36.
B. K. Vonderhaar (1984). Hormone and growth factors in mammary gland development. In C. M. Veneziale (eds.), Control of Cell Growth and Proliferation, Van Nostrand-Reinhold, Princeton, pp. 11–33.
K. Plaut, M. Ikeda, and B. K. Vonderhaar (1993). Role of growth hormone and insulin-like growth factor-I in mammary development. Endocrinology 133:1843–1848.
W. Imagawa, J. Yang, R. Guzman, and S. Nandi (1994). Control of Mammary Gland Development. In E. Knobrl and J. D. Neill (eds.), The Physiology of Reproduction, Raven Press, New York, pp. 1033–1063.
W. T. Schrader and B. W. O'Malley (1972). Progesterone-binding components of chick oviduct. IV. Characterization of purified subunits. J. Biol. Chem. 247:51–59.
L. Tung, M. K. Mohamed, J. P. Hoeffler, G. S. Takimoto, and K. B. Horwitz (1993). Antagonist-occupied human progesterone B-receptors activate transcription without binding to progesterone response elements and are dominantly inhibited by A-receptors. Mol. Endocrinol. 7:1256–1265.
M. Beato, P. Herrlich, and G. Schutz (1995). Steroid hormone receptors: many actors in search of a plot. Cell 83:851–857.
M. J. Tsai and B. W. O'Malley (1994). Molecular mechanisms of action of steroid/thyroid receptor superfamily members. Ann. Rev. Biochem. 63:451–486.
S. Z. Haslam (1989). The ontogeny of mouse mammary gland responsiveness to ovarian steroid hormones. Endocrinology 125:2766–2772.
P. Kastner, A. Krust, B. Turcotte, U. Strupp, L. Tora, H. Gronemyer, and P. Chambon (1990). Two distinct estrogen-regulated promoters generate transcripts encoding the two functionally different human progesterone receptor forms A and B. EMBO J. 9:1603–1614.
A. Guiochon-Mantel, H. Loosfelt, P. Lescop, S. Christin-Maitre, M. Perrot-Applanat, and E. Milgrom (1992). Mechanisms of nuclear localization of the progesterone receptor. J. Steroid Biochem. 41:209–215.
G. Shyamala and A. Ferenczy (1984). Mammary fat pad may be a potential site for initiation of estrogen action in normal mouse mammary glands. Endocrinology 115:1078–1081.
G. B. Silberstein, K. Van Horn, G. Shyamala, and C. W. Daniel (1996). Progesterone receptors in the mouse mammary duct: distribution and developmental regulation. Cell Growth Diff. 7:945–952.
S. L. Mansour, K. R. Thomas, and M. R. Capecchi (1988). Disruption of the proto-oncogene int-2 in mouse embryo-derived stem cells: a general strategy for targeting mutations to non-selectable genes. Nature 336:348–352.
Q. Hou and J. Gorski (1993). Estrogen receptor and progesterone receptor genes are expressed differentially in mouse embryos during preimplantation development. Proc. Natl. Acad. Sci. U.S.A. 90:9460–9464.
D. B. Lubahn, J. S. Moyer, T. S. Golding, J. F. Couse, K. S. Korach, and O. Smithies (1993). Alteration of reproductive function but not prenatal sexual development after insertional disruption of the mouse estrogen receptor gene. Proc. Natl. Acad. Sci. U.S.A. 90:162–166.
W. P. Boccinfuso and K. S. Korach (1997). Mammary gland development and tumorigenesis in estrogen receptor knockout mice. J. Mam. Gland Biol. Neoplasia 2:323–334.
E. Baldi, C. Krauz, M. Luconi, L. Bonaccorsi, M. Maggi, and G. Forti (1995). Actions of progesterone on human sperm: a model of non-genomic effects of steroids. J. Steroid Biochem. Mol. Biol. 53:199–203.
S. K. Mani, J. M. Allen, J. P. Lydon, B. Mulac-Jericevic, J. D. Blaustein, F. J. DeMayo, O. Conneely, and B. W. O'Malley (1996). Dopamine requires the unoccupied progesterone receptor to induce sexual behavior in mice. Mol. Endocrinol. 10:1728–1737.
C. L. Clarke and R. L. Sutherland (1990). Progestin regulation of cellular proliferation. Endocrine Rev. 11:266–300.
F. Bresciani (1968). Topography of DNA synthesis in the mammary gland of the C3H mouse and its control by ovarian hormones: an autoradiographic study. Cell Tissue Kinet. 1:51–63.
G. Shyamala (1987). Endocrine and other influences in the normal development of the breast. In A. H. G. Paterson and A. W. Lees (eds.), Fundamental Problems in Breast Cancer, Martinus Nijhof, Boston, pp. 127–137.
W. Imagawa, Y. Tomooka, S. Hamamoto, and S. Nandi (1985). Stimulation of mammary epithelial cell growth in vitro and interaction of epidermal growth factor and mammogenic hormones. Endocrinology 116:1514–1524.
K. B. Horwitz (1992). The molecular biology of RU486. Is there a role for antiprogestins in the treatment of breast cancer? Endocrine Rev. 13:146–163.
C. W. Welsch (1985). Host factors affecting the growth of carcinogen-induced rat mammary carcinomas: a review and tribute to Charles Brenton Huggins. Cancer Res. 45:3415–3443.
S. P. Robinson and V. C. Jordan (1987). Reversal of the antitumor effects of tamoxifen by progesterone in the 7, 12-dimethyl-benzanthracene-induced rat mammary carcinoma model. Cancer Res. 47:5386–5390.
N. Nagasawa, M. Aoki, N. Sakagami, and M. Ishida (1988). Medroxyprogesterone acetate enhances spontaneous mammary tumorigenesis and uterine adenomyosis in mice. Breast Cancer Res. Treatment 12:59–66.
E. A. Musgrave, J. A. Hamilton, C. S. Lee, K. J. E. Sweeney, C. K. W. Watts, and R. L. Sutherland (1993). Growth factor, steroid, and steroid antagonist regulation of cyclin gene expression associated with changes in T-47D human breast cancer cell cycle progression. Mol. Cell. Biol. 13:3577–3587.
E. A. Musgrave, C. S. L. Lee, A. L. Cornish, A. Swarbrick, and R. L. Sutherland (1997). Antiprogestin inhibition of cell cycle progression in T-47D breast cancer cells is accompanied by induction of cyclin-dependent kinase inhibitor p21. Mol. Endocrinol. 11:54–66.
P. Sicinski, J. L. Donaher, S. B. Parker, T. Li, A. Fazeli, H. Gardner, S. Z. Haslam, R. T. Bronson, S. J. Elledge, and R. A. Weinberg (1995). Cyclin D1 provides a link between development and oncogenesis in the retina and breast. Cell 82:621–630.
V. Fantl, G. Stamp, A. Andrews, I. Rosewell, and C. Dickson (1995). Mice lacking cyclin D1 are small and show defects in eye and mammary gland development. Genes Devel. 9:2364–2372.
P. Sicinski and R. A. Weinberg (1997). A specific role for cyclin D1 in mammary gland development. J. Mam. Gland Biol. Neoplasia 2:335–342.
L. Stepanova, X. Leng, S. B. Parker, and J. W. Harper (1996). Mammalian p50Cdc37 is a protein kinase-targeting subunit of Hsp 90 that binds and stabilized Cdk4. Genes Devel. 10:1491–1502.
K. Kratochwil (1986). Tissue combination and organ culture studies in the development of the embryonic mammary gland. Devel. Biol. 4:315–333.
C. W. Daniel, L. J. Young, D. Medina, and K. B. DeOme (1971). The influence of mammogenic hormones on serially transplanted mouse mammary gland. Exp. Gerontol. 6:95–101.
K. K. Sekhri, D. R. Pitelka, and K. B. DeOme (1967). Studies of mouse mammary glands. II. Cytomorphology of mammary transplants in inguinal fat pads, nipple-excised host glands, and whole mammary-gland transplants. J. Natl. Cancer Inst. 39:491–527.
G. R. Cuhna and Y. K. Hom (1996). Role of mesenchymal-epithelial interactions in mammary gland development. J. Mam. Gland Biol. Neoplasia 1:21–36.
G. R. Cunha, P. Young, Y.-K. Hom, P. S. Cooke, J. A. Taylor, and D. B. Lubahn (1997). Mechanism of estrogen action in mesenchymal-epithelial interaction in the mammary gland. J. Mam. Gland Biol. Neoplasia 2:393–402.
R. C. Humphreys, J. Lydon, B. W. O'Malley, and J. M. Rosen (1997). Mammary gland development is mediated by both stromal and epithelial progesterone receptors. Mol. Endocrinol. 11:801–811.
S. Coleman, G. B. Silberstein, and C. W. Daniel (1988). Ductal morphogenesis in the mouse mammary gland: evidence supporting a role for epidermal growth factor. Devel. Biol. 127:304–315.
Y. Yang, E. Spitzer, D. Meyer, M. Sachs, C. Niemann, G. Hartmann, K. M. Weidner, C. Birchmeier, and W. Birchmeier (1995). Sequential requirement of hepatocyte growth factor and neuregulin in the morphogenesis and differentiation of the mammary gland. J. Cell Biol. 131:215–226.
B. Niranjan, L. Buluwela, J. Yant, N. Perusinghe, A. Atherton, D. Phippard, T. Dale, B. Gusterson, and T. Kamalati (1995). HGF/SF: a potent cytokine for mammary growth, morphogenesis and development. Development 121:2897–2908.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Humphreys, R.C., Lydon, J.P., O'Malley, B.W. et al. Use of PRKO Mice to Study the Role of Progesterone in Mammary Gland Development. J Mammary Gland Biol Neoplasia 2, 343–354 (1997). https://doi.org/10.1023/A:1026343212187
Issue Date:
DOI: https://doi.org/10.1023/A:1026343212187